In the immuno-oncology field, scientists discover, test, and validate novel immunotherapeutic agents that leverage the human immune system to fight cancer, such as checkpoint inhibitors, vaccine-based ...
This interview dives into Curisosis' live cell imaging systems and how they improve reproducibility in cell-based assays.
Understanding the differences between biochemical and cell-based assays is key to choosing the right high-throughput ...
Scientists use multi-day live cell assays to monitor cell growth, viability, and cytotoxicity when evaluating the effects of drug treatment. However, maintaining consistent cell health over time ...
OTC deficiency is a rare genetic condition and the most prevalent urea cycle disorder. Newborns with neonatal onset OTC deficiency exhibit hyperammonemia symptoms shortly after birth, including ...
This article examines target-based vs phenotypic screening, comparing mechanisms, advantages, limitations, and use cases to ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...
Morning Overview on MSN
DNA-based system targets cancer cells and releases drugs at tumors
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...
Morning Overview on MSN
New synthetic-cell system boosts flexibility in mimicking cellular functions
Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results